UBTECH Smart Elderly Care Solution honored as the winner of the 2023 Edison Awards™

FORT MYERS, FLORIDA, USA, April 24, 2023 (GLOBE NEWSWIRE) — FORT MYERS, FLORIDA, April 20, 2023– UBTECH, a leading global AI and robotics company, was honored the Bronze award of the 2023 Edison Awards™’ MedTech category for the distinguished innovation of its Smart Elderly Care Solution.

Known as the “Oscars of tech,” the Edison Awards™ is one of the oldest and most prestigious technology awards. It honors the most impactful brands and business leaders worldwide, with past winners including Steve Jobs, Elon Musk, General Motors, and Genentech, recognizing their excellence in service development, marketing, design, and innovation.

All nominations were reviewed by the Edison Awards Steering Committee with the final ballot determined by an independent judging panel. The panel is comprised of more than 3,000 senior business executives and academics from the fields of product development, design, engineering, science, marketing and education, as well as past winners.

UBTECH’s Smart Elderly Care Solution offers an enriched portfolio of intelligent robots to enhance the quality of life for seniors. In addition to using cutting-edge robotics technologies, the solution also leverages advanced artificial intelligence. And through UBTECH’s Smart Healthcare Cloud Platform, the Smart Elderly Care Solution creates a network that enables seamless integration of a variety of devices. This interconnect between hardware, network and people supports the seven key scenarios of smart elderly care: operational management, safety and security, health management, daily care, rehabilitation, mental and physical activities, and nutrition and diet.

“This is the industry’s comprehensive solution that combines advanced robotics and AI technology to assist seniors and their caregivers in nursing homes. Rather than providing services using isolated, individual products, we focus on addressing system-level challenges. By extensively applying AI technology, we vastly improved product performance to bring a richer, more optimized experience to the elderly and caregivers,” Henry Tan, Co-Chief Technology Officer of UBTECH and General Manager of UBTECH Healthcare, says, “It is an honor to have our Smart Elderly Care Solution be recognized by the Edison Awards™.”

According to the U.S. Census Bureau, starting in 2030, all baby boomers will be 65 and older. And by 2034, older adults will outnumber children for the first time in U.S. history. This forecast generates demand for efficient, comprehensive assistive care solutions.

Designed for accessibility, UBTECH’s Smart Elderly Care Solution portfolio accepts a multitude of inputs. Its smart sensors, working in parallel with its data platform, transform care from passive to proactive in assisting with daily tasks. And with rich interactive features, the solution can support seniors’ physical and mental well-being.

Moving into the smart care era, UBTECH provides people with an intelligent, independent, and convenient solution to raise the standard for the elderly care industry. Within the past year, UBTECH has released five service robots: Wassi, an intelligent walking assistance robot; VerCari, a containerized delivery robot; PathFynder, a smart wheelchair; AuCari, an open delivery robot; and Welli, a companion robot.

Due to its utility and innovation, UBTECH’s Smart Elderly Care Solution is garnering international interest. The PathFynder smart wheelchair is now exploring market in North America. In addition, UBTECH has worked with companies and partners to deliver and implement the solution in different facilities and scenarios. These successes are encouraging UBTECH to continue its mission to refine its technologies, pushing the industry forward to promote a higher quality of care.

As UBTECH expands its business globally, it expects to generate higher value and provide higher-quality services for seniors worldwide. By continuing to develop robotics and AI, the company aims to address the long-term challenge for society and create a new industry to boost the global economy.


UBTECH, established in March 2012, is a leading AI and robotics company specializing in service robotics research, manufacturing, and marketing. Throughout the ongoing journey, from establishing an R&D center in North America focusing on the healthcare sector in 2019 focusing on applying solutions in various elderly-care scenarios, to releasing its global strategy for smart elderly-care in 2022, UBTECH has been a pioneer and leader in smart service robotic solutions. UBTECH is committed to the vision of transforming the healthcare industry and the sustainable development of the elderly-care economy with innovative technologies, together with industry partners.

Press contact

Jade Su

Senior PR Manager



Cindy Li

GlobeNewswire Distribution ID 8824058

Fortinet Survey Finds 78% of Organizations Felt Prepared for Ransomware Attacks, Yet Half Still Fell Victim

Organizations taking a best-of-breed, point product approach to security were more likely to be attacked by ransomware in the last year

SUNNYVALE, Calif., April 24, 2023 (GLOBE NEWSWIRE) — RSAC 2023

John Maddison, EVP of Products and CMO at Fortinet
“According to the Fortinet research released today, though three out of four organizations detected ransomware attacks early, half still fell victim to them. These results demonstrate the urgency to move beyond simple detection to real-time response. However, this is only part of the solution as organizations cited the top challenges in preventing attacks were related to their people and processes. A holistic approach to cybersecurity that goes beyond investing in essential technologies and prioritizes training is essential.”

News Summary

Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today unveiled its 2023 Global Ransomware Report. The report is based on a recent global survey conducted by Fortinet and explores cybersecurity leaders’ perspectives on ransomware, particularly how it impacted their organizations in the last year, and their strategies to mitigate an attack. Key findings from the global survey include:

  • The global threat of ransomware remains at peak levels, with half of organizations across all sizes, regions and industries falling victim in the last year.
  • The top challenges to stopping a ransomware attack were people and process related, with many organizations lacking clarity on how to secure against the threat.
  • There are a range of technologies viewed as essential to prevent ransomware, with an overwhelming majority prioritizing an integrated approach to security.
  • Despite the global macroeconomic environment, security budgets will increase in the next year with a focus on AI/ML technologies to speed detection, centralized monitoring tools to speed response, and better preparation of people and processes.

A Growing Disconnect Between Ransomware Preparedness and Prevention

Fortinet’s research revealed there was a large disconnect between respondents’ level of preparedness with existing strategies and their ability to stop a ransomware attack. Although 78% of organizations stated they were “very” or “extremely” prepared to mitigate an attack, the survey found 50% fell victim to ransomware in the last year, and almost half were targeted two or more times. Specifically, four out of the five top challenges to stopping ransomware were people or process related. The second largest challenge was a lack of clarity on how to secure against the threat as a result of a lack of user awareness and training, and no clear chain-of-command strategy to deal with attacks.

More Organizations are Paying the Ransom, Despite Industry Guidance

The survey also found that despite most (72%) detecting an incident within hours, and sometimes minutes, the percentage of organizations paying ransoms remains high, with almost three-quarters of respondents making some form of ransom payment. When comparing across industries, organizations in the manufacturing sector received higher ransoms and were more likely to pay the fee. Specifically, one quarter of attacks among manufacturing organizations received a ransom of $1M or higher. Finally, while almost all organizations (88%) reported having cyber insurance, almost 40% didn’t receive as much coverage as expected and, in some cases, didn’t receive any because of an exception from the insurer.

Security Budgets will Increase Despite Economic Uncertainty

With concerns about ransomware still high and despite a challenging global economic environment, nearly all organizations (91%) expect increased security budgets in the next year. Based on the technologies viewed as most essential to secure against ransomware, organizations were most concerned with IoT SecuritySASECloud Workload ProtectionNGFWEDRZTNA, and Security Email Gateway. When comparing to 2021, the number of respondents citing ZTNA and Secure Email Gateway increased by nearly 20%. Given email phishing remained the most common attack entry method for the second time, it was promising to see respondents view Secure Email Gateway (51%) with higher importance, however, other essential protections, such as Sandboxing (23%) and Network Segmentation (20%) remained low on the list.

In the future, top priorities for respondents will be investing in advanced technology powered by AI and ML to enable faster threat detection and central monitoring tools to speed response. These investments will help organizations combat a rapidly evolving threat landscape as cyber attackers become more aggressive and deploy new elements into attacks.

Enhancing Ransomware Protection Through a Platform Approach

In addition, the report found that organizations using point products were the most likely to fall victim to an attack in the last year, while those who had consolidated to a smaller number of platforms were the least likely to be a victim. Further, almost all respondents (99%) viewed integrated solutions or a platform as essential to preventing ransomware attacks. These findings underscore the importance of leveraging a unified platform approach to defend against ransomware.

Fortinet supports organizations looking to improve their processes and advance cybersecurity skills by providing services such as Incident Readiness Assessments and Tabletop ExercisesRansomware Readiness AssessmentsSOC-as-a-Service, and SOC Readiness Assessments, as well as comprehensive training from one of the largest programs in the industry, the Fortinet Training Institute. With its industry-leading Security Fabric of over 50 natively integrated, enterprise-grade products, Fortinet continues to be the leading vendor helping organizations consolidate their point products into a unified cybersecurity platform. This platform approach, with open APIs and a robust Fabric-Ready technology alliance ecosystem, enables CISOs and security teams to reduce complexity, increase efficacy in the prevention and detection of ransomware, and speed incident triage, investigation and response.

Learn More about the Fortinet Security Fabric in the Fortinet Booth at RSA 2023

Fortinet is a Platinum Sponsor at this year’s RSA Conference and will be showcasing live demonstrations of its Security Fabric and cybersecurity solutions at booth #5863. Stop by the booth for a range of interactive discussions on how to protect your business from ransomware and learn more about Fortinet and its presentations at RSA in this blog post.

Report Overview:

  • The survey was conducted among 569 cybersecurity leaders from 31 different locations around the world, including the United States, United Kingdom, France, India, and Japan, among others.
  • Survey respondents came from a range of industries, such as manufacturing (29%), technology (19%), transportation (12%) and healthcare (11%).

Additional Resources

About Fortinet

Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere you need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.


Copyright © 2023 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiCWP, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFone, FortiGSLB, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMoM, FortiMonitor, FortiNAC, FortiNDR, FortiPenTest, FortiPhish, FortiPlanner, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM and FortiXDR. Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

Media Contact: Investor Contact: Analyst Contact:
Camille Burdge
Fortinet, Inc.
Peter Salkowski
Fortinet, Inc.
Brian Greenberg
Fortinet, Inc.

GlobeNewswire Distribution ID 8813162

Duck Creek Technologies Unveils a “Who’s Who” Participating in the Insurance Industry’s Leading Conference for Tech Decision Makers, Formation ’23

The world’s leading insurance industry and technology minds gather in Orlando, FL, May 8-10, 2023

Boston, April 24, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, announces major sponsors, partners, and presenters joining the leading insurance technology decision makers for its upcoming marquee customer conference, Formation ’23. The event is being held May 8 through May 10, 2023, at Signia by Hilton Orlando Bonnet Creek in Orlando, Florida.

With a focus on cultivating a world-class event experience filled with rich content, industry networking opportunities and unforgettable activities, Formation ‘23 is all about “BUILDING TOGETHER.” Duck Creek will welcome the leading insurtech minds and industry professionals of all levels from across the globe in a high-energy environment with ample educational and networking opportunities focused on the latest trends and innovations empowering the insurance industry. Duck Creek is delighted to be joined on stage and in sessions by customers who will share their personal stories and first-hand experiences implementing Duck Creek and partner ecosystem innovations. Notable carriers presenting include Australia-based general insurers Argyle and Hollard, as well as Berkshire Hathaway Specialty Insurance, EMC Insurance Companies, GAINSCO Auto Insurance® (GAINSCO), Great American Insurance Group, Indigo Insurance Ltd., and Munich Reinsurance America, Inc.

“This year we have a record number of sponsorship commitments from more than 60 members of our partner ecosystem, including diamond sponsors Glia and LTIMindtree; platinum sponsors Coforge and EY; and gold sponsors Accenture, Aggne Global, Capgemini, Cognizant and Quadient,” said Rohit Bedi, Chief Revenue Officer, Duck Creek Technologies. “This is a testimony to the robust partner ecosystem Duck Creek has built to benefit our customers worldwide. We maintain strong relationships with industry leaders to provide complementary, distinct solutions and services to get our joint customers to market quickly.”

Notably, several influential industry analysts from Aite-Novarica Group (Aite-Novarica), Celent, Everest Group, Forrester, International Data Corporation (IDC) and ReSource Pro Consulting, will participate in various sessions as guest speakers. In particular, Aite-Novarica, Celent, and Forrester will come together to speak in a panel, “Building the future together,” to share how insurers must utilize technology to win in today’s market.

Attendees will get first look at Duck Creek’s latest product vision, strategy, and roadmap. “Duck Creek is committed to providing great products that enable insurers and their customers to thrive,” said Chief Product & Technology Officer Jess Keeney. “We believe great products are personal – delivered and supported through the research and development of humanized experiences. Insurance is more complex with more regulations than ever, and we provide our customers with better data and more technology to manage increased distribution channels and shifting demographics.”

The agenda and speaker line-up are now available on the conference website. For more information on Formation ‘23 or to register now for the year’s must-attend event, please visit https://www.duckcreek.com/formation/.

About Duck Creek Technologies

Duck Creek Technologies is the intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry. We are the platform upon which modern insurance systems are built, enabling the industry to capitalize on the power of the cloud to run agile, intelligent, and evergreen operations. Authenticity, purpose, and transparency are core to Duck Creek, and we believe insurance should be there for individuals and businesses when, where, and how they need it most. Our market-leading solutions are available on a standalone basis or as a full suite, and all are available via Duck Creek OnDemand. Visit www.duckcreek.com to learn more. Follow Duck Creek on our social channels for the latest information – LinkedIn and Twitter.

Carley Bunch
Duck Creek Technologies

GlobeNewswire Distribution ID 8813214

Gorilla Technology Group Announces Clarification to Registration Statement on Form F-1

Barring exercise of warrants, securities registered in F-1 will not cause dilution to existing holders of ordinary shares

LONDON, April 24, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR) made an announcement regarding its resale registration statement on Form F-1 (the “Registration Statement”), which went effective on March 30, 2023. Gorilla wishes to clarify that the purpose of filing the Registration Statement was not for a new issuance of ordinary shares by the Company and will not result in dilution to its ordinary shareholders (barring the exercise of the Company’s outstanding options or warrants).

As of the date of filing of the Registration Statement, the Company had 68,629,774 ordinary shares outstanding (excluding treasury shares). Notwithstanding the cover page of the prospectus in the Registration Statement and the securities registered therein, no additional ordinary shares were outstanding following its effectiveness and there are no securities currently outstanding which may cause the number of ordinary shares outstanding to increase other than (1) employee stock options and (2) warrants (all of which have an exercise price of $11.50).

While the Registration Statement states that it is partly for a “primary offering” of ordinary shares, this is only to register ordinary shares underlying the Company’s previously issued contingent value rights (“CVRs”) and will not increase the number of outstanding ordinary shares of Gorilla. If ordinary shares are required to be issued to the holders of CVRs, such issuance will be fully offset (if not more than fully offset) by the forfeiture and cancellation of Earnout Shares (as defined in the Company’s Business Combination Agreement). The Earnout Shares are currently held in escrow by the Company’s transfer agent but are treated as outstanding in all the Company’s filings (as they may be voted, even if economic rights have not yet vested). The number of ordinary shares registered in the Registration Statement pursuant to the “secondary offering” included these Earnout Shares and are reflected in the holdings of the selling security holders (if a selling security holder has a potential claim to such Earnout Shares).

About Gorilla Technology Group Inc.
Gorilla, headquartered in London U.K., is a global solution provider in security intelligence, network intelligence, business intelligence and IoT technology. Gorilla develops a wide range of solutions including Smart Cities, Smart Retail, Enterprise Security, and Smart Media. In addition, Gorilla provides a complete Security Convergence Platform to government institutions, telecom companies and private enterprises with network surveillance and cyber security.

Gorilla places an emphasis on offering leading technology, expert service, and precise delivery, and ensuring top-of-the-line, intelligent and strong edge AI solutions that enable clients to improve operational performance and efficiency. With continuous core technology development, Gorilla will deliver edge AI solutions to managed service providers, distributors, system integrators, and hardware manufacturers. For more information, please visit our website: Gorilla-Technology.com.

Forward-Looking Statements
This press release contains forward-looking statements, which are based on estimates, assumptions, and expectations. Actual results and performance could differ materially and adversely from those expressed or implied in forward-looking statements. Gorilla does not undertake any obligation to update any forward-looking statements, except as required by law.

Jeff Fox
The Blueshirt Group for Gorilla
+1 (415) 828-8298

GlobeNewswire Distribution ID 8823452

Philips delivers solid operational performance as supply chain improves and actions to enhance execution start to take effect

April 24, 2023

First-quarter highlights

  • Group sales increased to EUR 4.2 billion, with 6% comparable sales growth
  • Comparable order intake growth was flat, with double-digit growth in the Diagnosis & Treatment businesses, offset by a decline in the Connected Care businesses
  • Income from operations amounted to a loss of EUR 583 million, mainly due to provisions for accelerated restructuring and an important step in litigation
  • EUR 575 million litigation provision is related to the anticipated resolution of the Respironics recall-related economic loss class action in the US
  • Adjusted EBITA increased to EUR 359 million, or 8.6% of sales, compared to EUR 243 million, or 6.2% of sales, in Q1 2022
  • Operating cash flow improved to EUR 202 million, compared to an outflow of EUR 227 million in Q1 2022
  • Simplification of operating model and restructuring plans on track

Roy Jakobs, CEO of Royal Philips:
“I am encouraged that we delivered a solid start to the year, with sales, profitability and operating cash flow improvements in the quarter, a first step to drive progressive value creation. We are executing on our three priorities to enhance patient safety and quality, strengthen our supply chain reliability, and establish a simplified, more agile operating model.

Resolving the Philips Respironics recall for patients remains our highest priority. In the first quarter, we have recorded a provision in anticipation of a resolution of the economic loss class action in the US. This is an important step in addressing the litigation related to the recall.

Our supply chain improvements enabled good growth across the Diagnosis & Treatment businesses and in Hospital Patient Monitoring. Supported by significant change management efforts, we have reduced the workforce by approximately 5,400 roles out of the planned reduction of 10,000 roles globally.

I realize that we are asking a lot from our employees to work through the necessary changes and deeply appreciate their tremendous efforts and ongoing commitment to deliver on our company purpose. I would also like to thank our customers and partners for their continued trust and support. I have met many of them in the last few months, and it is clear that Philips remains a preferred innovation partner.

Looking ahead, based on our solid performance in the quarter, our order book, and the ongoing actions to further improve execution, we are confident in our plan for the year 2023, acknowledging that uncertainties remain.”

Group and business segment performance
Sales for the Group increased to EUR 4.2 billion, with 6% comparable sales growth, mainly driven by the Diagnosis & Treatment businesses. Additionally, sales in the quarter were supported by the good momentum for the Diagnosis & Treatment and Connected Care businesses in China. Adjusted EBITA for the Group increased to EUR 359 million, or 8.6% of sales, mainly due to increased sales and productivity measures, partly offset by cost inflation. Philips’ order book remains strong and is 10% higher than one year ago despite flat order intake growth.

The Diagnosis & Treatment businesses’ comparable sales increased by a strong 15% in the quarter, with double-digit growth in Ultrasound and Image-Guided Therapy, and mid-single-digit growth in Diagnostic Imaging, driven by continued supply chain improvements. Comparable order intake grew double-digit, with double-digit growth in Image-Guided Therapy and Enterprise Diagnostic Informatics and mid-single-digit growth in Diagnostic Imaging. The Adjusted EBITA margin increased to 11.3%, which was mainly due to increased sales and productivity measures, partly offset by cost inflation.

The Connected Care businesses’ comparable sales increased 3% in the quarter, driven by double-digit growth in Hospital Patient Monitoring, largely offset by a decline in Sleep & Respiratory Care. Comparable order intake declined double-digit after strong growth in the period between 2020 and 2022. The Adjusted EBITA margin increased to 2.4%, driven by the improved Adjusted EBITA margin of the Connected Care businesses excluding Sleep & Respiratory Care.

The Personal Health businesses’ comparable sales decreased by 6% in the quarter due to the anticipated lower consumer demand, on the back of 8% growth in Q1 2022. The Adjusted EBITA margin amounted to 13.2%. Sales and Adjusted EBITA were both significantly impacted by portfolio decisions related to Russia in 2022.


In the first quarter, operating model productivity savings amounted to EUR 94 million, procurement savings amounted to EUR 32 million, and other productivity programs delivered savings of EUR 64 million, resulting in total savings of EUR 190 million.

Customer and innovation highlights

  • In the quarter, the company announced multiple new partnerships, demonstrating the confidence hospital leaders have in Philips’ innovative portfolio. These include an agreement with Grupo Angeles, the largest private hospital group in Mexico, to provide informatics, diagnostic imaging and image-guided therapy solutions to advance patient care in cardiology, oncology and radiology.
  • Highlighting the strength of its comprehensive patient monitoring offering, Philips announced a multi-year partnership with Northwell Health to standardize and centralize patient monitoring across the hospital, allowing caregivers to see what is happening at each bedside.
  • Leveraging its leading expertise in sustainable healthcare operations, Philips announced a multi-year agreement with Champalimaud Foundation in Portugal aimed at halving its diagnostic imaging carbon footprint by 2028. The partnership will help drive quality and efficiency, while reducing environmental impact.
  • Philips further expanded its industry-leading ultrasound portfolio with the launch of Ultrasound Compact 5500 CV, which enables first-time-right ultrasound exams for cardiology and vascular patients at the bedside.
  • To improve oral care habits among children, Philips introduced Sonicare for Kids ‘Design a Pet Edition’ with an entry price point designed to give more parents access to an electric toothbrush for their children.
  • Philips took a top ranking in medical technology patent filings at the European Patent Office and was included on the Clarivate Top 100 Global Innovator list for the 10th year in a row.

Philips Respironics field action for specific sleep therapy and ventilator devices
To date, more than 95% of the new replacement devices and repair kits required for the remediation of the registered devices have been produced. The vast majority of the produced sleep therapy devices have been sent to patients and home care providers. The remaining 5% of the registered devices are primarily ventilators, for which Philips Respironics is fully focused on working towards a solution.

In Q2 2023, Philips Respironics expects to report on the VOC testing of ozone-induced foam degradation in the first-generation DreamStation devices, and on the complete set of testing results for the SystemOne and DreamStation Go sleep therapy devices.

As previously disclosed, Philips is a defendant in several class-action lawsuits and individual personal injury claims. In the US, an economic loss class action, a medical monitoring class action and personal injury claims have been filed. This quarter, Philips Respironics recorded a EUR 575 million provision in connection with the anticipated resolution of the economic loss class action, an important step in addressing the litigation related to the recall.

Philips Respironics is subject to an investigation by the US Department of Justice and remains in ongoing discussions with the FDA regarding a proposed consent decree. Given the uncertain nature of the relevant events, and of their potential financial and operational impact and associated obligations, if any, the company has not made any provisions in the accounts for these matters.

Click here to view the release online

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements and other important information

Forward-looking statements

This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future Adjusted EBITA*), future restructuring and acquisitionrelated charges and other costs, future developments in Philips’ organic business and the completion of acquisitions and divestments. Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

These factors include but are not limited to: Philips’ ability to gain leadership in health informatics in response to developments in the health technology industry; Philips’ ability to transform its business model to health technology solutions and services; macroeconomic and geopolitical changes; integration of acquisitions and their delivery on business plans and value creation expectations; securing and maintaining Philips’ intellectual property rights, and unauthorized use of third-party intellectual property rights; Philips’ ability to meet expectations with respect to ESG-related matters; failure of products and services to meet quality or security standards, adversely affecting patient safety and customer operations; breaches of cybersecurity; challenges in connection with Philips’ strategy to improve execution and other business performance initiatives; the resilience of our supply chain; attracting and retaining personnel; COVID-19 and other pandemics; challenges to drive operational excellence and speed in bringing innovations to market; compliance with regulations and standards including quality, product safety and (cyber) security; compliance with business conduct rules and regulations including privacy and upcoming ESG disclosure and due diligence requirements; treasury and financing risks; tax risks; reliability of internal controls, financial reporting and management process; global inflation. For a discussion of factors that could cause future results to differ from such forward-looking statements, see also the Risk management chapter included in the Annual Report 2022.

Philips has recognized a provision related to the voluntary recall notification in the US/field safety notice outside the US for certain sleep and respiratory care products, based on Philips’ best estimate for the expected field actions. Future developments are subject to significant uncertainties, which require management to make estimates and assumptions, about items such as quantities and the portion to be replaced or repaired. Actual outcomes in future periods may differ from these estimates and affect the company’s results of operations, financial position and cash flows. Furthermore, Philips is a defendant in several class-action lawsuits and individual personal injury claims, and is in ongoing discussions with the FDA regarding a proposed consent decree. Given the uncertain nature of the relevant events, and of their potential financial and operational impact and associated obligations, if any, the company has not made any provisions in the accounts for these matters, except for the following. In the first quarter of 2023, Philips Respironics recorded a provision in connection with an anticipated resolution of the economic loss class action pending in the US. The provision is subject to final resolution and court approval of the negotiated settlement agreement and is based on Philips’ best estimate for the expected settlement amounts, which is, in part, based on the expected number of claims ultimately filed pursuant the settlement once it is approved. Actual outcomes in future periods of the above matters may differ from these estimates and affect the company’s results of operations, financial positions and cash flows.

Third-party market share data

Statements regarding market share, contained in this document, including those regarding Philips’ competitive position, are based on outside sources such as specialized research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, market share statements may also be based on estimates and projections prepared by management and/or based on outside sources of information. Management’s estimates of rankings are based on order intake or sales, depending on the business.

Market Abuse Regulation

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. This press release was distributed at 07:00 am CET on April 24, 2023.

Use of non-IFRS information

In presenting and discussing the Philips Group’s financial position, operating results and cash flows, management uses certain non-IFRS financial measures. These non-IFRS financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measure and should be used in conjunction with the most directly comparable IFRS measures. Non-IFRS financial measures do not have standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. A reconciliation of these non-IFRS measures to the most directly comparable IFRS measures is contained in this document. Further information on non-IFRS measures can be found in the Annual Report 2022.

Use of fair value information

In presenting the Philips Group’s financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in the Annual Report 2022. In certain cases, independent valuations are obtained to support management’s determination of fair values.


All amounts are in millions of euros unless otherwise stated. Due to rounding, amounts may not add up precisely to totals provided. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2022 except for the adoption of new standards and amendments to standards which are also expected to be reflected in the company’s consolidated IFRS financial statements as at and for the year ending December 31, 2023.

*) Non-IFRS financial measure. Refer to the Reconciliation of non-IFRS information

GlobeNewswire Distribution ID 1000805622

Industrial real estate remains attractive: Insiders

Industrial real estate has been a bright spot in the market thanks to a large amount of foreign investment inflows, great potential and high absorption capacity, according to experts.

Under the industrial park (IP) planning, Vietnam has 563 IPs with a total area of 210,900 hectares, including 361 outside and 37 inside economic zones, and eight in border economic areas.

Thomas Rooney, Senior Manager of Industrial Services at Savills Hanoi, said that Vietnam has lower economic risk than other emerging countries such as Myanmar, Bangladesh, Laos, Cambodia, and Malaysia.

At the same time, Vietnam has great advantages in labour supply and export opportunities to China, along with stable domestic consuming power, he said.

However, the expert held that although Vietnam is one of the countries that invest strongly in infrastructure system at 5% of the GDP, it needs to pay greater attention to expressway, deep-water port and service port projects. He advised Vietnam to make more investment in human resources and infrastructure to increase the attractiveness of industrial property in the time to come.

Statistics from CBRE Vietnam showed that as of the first quarter of 2023, the accumulated supply of industrial land in tier-2 markets in both the north and the south reached more than 20,300 hectares, of which more than 57% of the total supply was in the south. Both regions recorded a positive absorption rate of new leasable space in 2022, in which the new leasable area of the north increased by 35% year on year, while the southern market recorded an average growth of 58% year on year.

Strong demand from manufacturers as well as enhanced competitive advantage in the tier-2 markets have supported the industry’s recent activities in these markets. These areas are being offered for rent at more competitive rates than the tier-1 markets, while the available land reserve offers tenants more options.

At the same time, key infrastructure projects in both the north and the south have recently come into operation, thus improving connectivity from provinces to major cities.

Thanh Pham, Associate Director of Research and Consulting Department at CBRE Vietnam, said that as some locations in industrial zones in the tier-2 markets offer incentives on income tax and land rent reduction and exemption, the markets have attracted large-scale manufacturers and ready-built factory operators.

In the period from 2022 to the first quarter of 2023, CBRE recorded large-scale transactions with a scale of 10 hectares or more in northern provinces such as Bac Giang, Thai Binh, and Quang Ninh, mainly in the electronics and automobile sectors, she said./.

Source: Vietnam News Agency